WO2002022817A3 - Nuclear receptor l66 and methods of use - Google Patents
Nuclear receptor l66 and methods of use Download PDFInfo
- Publication number
- WO2002022817A3 WO2002022817A3 PCT/EP2001/010323 EP0110323W WO0222817A3 WO 2002022817 A3 WO2002022817 A3 WO 2002022817A3 EP 0110323 W EP0110323 W EP 0110323W WO 0222817 A3 WO0222817 A3 WO 0222817A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nuclear receptor
- methods
- relates
- fxr
- nucleic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- High Energy & Nuclear Physics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002213893A AU2002213893A1 (en) | 2000-09-16 | 2001-09-07 | Nuclear receptor l66 and methods of use |
EP01982261A EP1317542A2 (en) | 2000-09-16 | 2001-09-07 | Nuclear receptor l66 and methods of use |
CA002420932A CA2420932A1 (en) | 2000-09-16 | 2001-09-07 | Novel mammalian nuclear receptor l66 and methods of use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00120370.2 | 2000-09-16 | ||
EP00120370 | 2000-09-16 | ||
EP01111658.9 | 2001-05-14 | ||
EP01111658 | 2001-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002022817A2 WO2002022817A2 (en) | 2002-03-21 |
WO2002022817A3 true WO2002022817A3 (en) | 2003-03-27 |
Family
ID=26071406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/010323 WO2002022817A2 (en) | 2000-09-16 | 2001-09-07 | Nuclear receptor l66 and methods of use |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1317542A2 (en) |
AU (1) | AU2002213893A1 (en) |
CA (1) | CA2420932A1 (en) |
WO (1) | WO2002022817A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030109467A1 (en) * | 2001-11-15 | 2003-06-12 | Isis Pharmaceuticals Inc. | Antisense modulation of human FXR expression |
WO2003087140A1 (en) * | 2002-04-13 | 2003-10-23 | Lion Bioscience Ag | NON-PRIMATE FXRb AS A LANOSTEROL SENSING NUCLEAR HORMONE RECEPTOR AND RELATED USES |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021677A1 (en) * | 1995-01-13 | 1996-07-18 | The General Hospital Corporation | Retinoid x receptor-interacting polypeptides and related molecules and methods |
US5728548A (en) * | 1995-06-29 | 1998-03-17 | Genetics Institute, Inc. | Retinoid receptor-1 (RR1) and DNA encoding RR1 |
US6005086A (en) * | 1995-01-13 | 1999-12-21 | The Salk Institute For Biological Studies | Farnesoid activated receptor polypeptides, and nucleic acid encoding the same |
WO2000057915A1 (en) * | 1999-03-26 | 2000-10-05 | City Of Hope | Method of affecting cholesterol catabolism using nuclear bile acid receptor |
-
2001
- 2001-09-07 AU AU2002213893A patent/AU2002213893A1/en not_active Abandoned
- 2001-09-07 CA CA002420932A patent/CA2420932A1/en not_active Abandoned
- 2001-09-07 WO PCT/EP2001/010323 patent/WO2002022817A2/en not_active Application Discontinuation
- 2001-09-07 EP EP01982261A patent/EP1317542A2/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021677A1 (en) * | 1995-01-13 | 1996-07-18 | The General Hospital Corporation | Retinoid x receptor-interacting polypeptides and related molecules and methods |
US6005086A (en) * | 1995-01-13 | 1999-12-21 | The Salk Institute For Biological Studies | Farnesoid activated receptor polypeptides, and nucleic acid encoding the same |
US5728548A (en) * | 1995-06-29 | 1998-03-17 | Genetics Institute, Inc. | Retinoid receptor-1 (RR1) and DNA encoding RR1 |
WO2000057915A1 (en) * | 1999-03-26 | 2000-10-05 | City Of Hope | Method of affecting cholesterol catabolism using nuclear bile acid receptor |
Non-Patent Citations (5)
Title |
---|
DATABASE EMBL [online] XP002202974, Database accession no. AL358372 * |
DATABASE EMBL [online] XP002202975, Database accession no. AA974561 * |
HUBER REID M ET AL: "Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters.", GENE. NETHERLANDS 15 MAY 2002, vol. 290, no. 1-2, 15 May 2002 (2002-05-15), pages 35 - 43, XP002202973, ISSN: 0378-1119 * |
WANG H ET AL: "ENDOGENOUS BILE ACIDS ARE LIGANDS FOR THE NUCLEAR RECEPTOR FXR/BAR", MOLECULAR CELL, CAMBRIDGE, MA, US, vol. 3, May 1999 (1999-05-01), pages 543 - 553, XP000905175, ISSN: 1097-2765 * |
WONGI SEOL ET AL: "ISOLATION OF PROTEINS THAT INTERACT SPECIFICALLY WITH THE RETIONOIDX RECEPTOR: TWO NOVEL ORPHAN RECEPTORS", MOLECULAR ENDOCRINOLOGY, BALTIMORE, MD, US, vol. 9, no. 1, 1995, pages 72 - 85, XP000561076, ISSN: 0888-8809 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002022817A2 (en) | 2002-03-21 |
CA2420932A1 (en) | 2002-03-21 |
EP1317542A2 (en) | 2003-06-11 |
AU2002213893A1 (en) | 2002-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001079459A3 (en) | Polypeptides having haloperoxidase activity | |
WO2002012501A3 (en) | Anti-dual integrin antibodies, compositions, methods and uses | |
WO2001034646A3 (en) | Recombinant gelatins | |
WO2001079461A3 (en) | Polypeptides having haloperoxidase activity | |
WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
NO20003958L (en) | Tumor associated antigen derivatives from the MAGE family, and nucleic acid sequences encoding them, used for the production of fusion proteins and for vaccine compositions | |
WO2001029222A3 (en) | Polypeptides having phospholipase b activity and nucleic acids encoding same | |
WO2003089598A3 (en) | Polypeptides having xyloglucanase activity and nucleic acids encoding same | |
WO2003014079A8 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
CA2170515A1 (en) | Nucleotide sequences for novel protein tyrosine phosphatases | |
CA2167693A1 (en) | Melanoma-inhibiting protein | |
WO2004007664A3 (en) | Nucleic acid vectors | |
AU2001247848A1 (en) | Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines | |
WO2001098469A3 (en) | Polypeptides having peroxidase activity and nucleic acids encoding same | |
WO1997027276A3 (en) | Nucleic acids encoding polypeptides having absidia lipase activity | |
HK1068329A1 (en) | Process for the preparation of 2,6-naphthalenedicarboxylic acid | |
WO2001085762A3 (en) | Cancer diagnosis and assays for screening anti-cancer agents | |
WO2002022817A3 (en) | Nuclear receptor l66 and methods of use | |
WO2000041509A3 (en) | Polypeptides having acid phosphatase activity and nucleic acids encoding same | |
WO2001029032A8 (en) | Process for the preparation of paroxetine | |
NO20021727D0 (en) | Process for Preparation of 3,4-Methylene Dioxymandelic Acid | |
ATE253069T1 (en) | OPTICALLY PURE CAMPTOTHECINE ANALOGS, OPTICALLY PURE SYNTHESIS INTERMEDIATE PRODUCT AND METHOD FOR THE PRODUCTION THEREOF | |
WO2002083727A3 (en) | Nucleic acid sequences of hyperplasies and tumors of the thyroid | |
WO2000047723A3 (en) | Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same | |
WO2003007872A3 (en) | Process for the preparation of citalopram hydrobromide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001982261 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2420932 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2001982261 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001982261 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |